News Releases 2001

12-18-2001 Duke University Health System and MDS Laboratories sign Multi-Year Agreement
12-13-2001 MDS Reports Fourth Quarter and Fiscal 2001 Results
12-12-2001 New Chemogenomics Alliance Between MDS Pharma Services and Iconix Pharmaceuticals
12-11-2001 MDS Proteomics Names Anil K. Amlani Chief Financial Officer; Amlani Brings More Than 20 Years of Financial Expertise to MDS Proteomics
11-28-2001 MDS Technology Key to Anti-rejection Drug Monitoring Test
11-13-2001 Ventiv Health, MDS Pharma Services and Paul Capital Partners Form Strategic Alliance to Serve Life Sciences Industry
11-06-2001 MDS Inc. Appoints Clarence J. Chandran to the Board
11-05-2001 MDS Nordion Introduces Oncentra(TM) Oncology Information Management
10-08-2001 MDS Proteomics Extends Relationship to University of Southern Denmark Under the Direction of Dr. Matthias Mann
09-19-2001 MDS Reports Third Quarter Results
09-19-2001 MDS Inc. Third Quarter F2001 Management's discussion and analysis of operating results and financial position
09-11-2001 MDS Inc. Appoints IBM Executive to Board
08-27-2001 MDS Completes Integration of Life Sciences Businesses
08-15-2001 MDS and Signature Form Strategic Alliance to Develop and Commercialize Novel Drug Discovery Instrumentation
07-31-2001 MDS SCIEX Appoints New Senior Vice-President
07-30-2001 MDS Proteomics Unveils PepSea Technology, Enabling Targeted, High-Speed Protein Identification
07-24-2001 MDS Pharma Services Launches Revolutionary, Internet-Based Data Delivery Platform, MDS Pharma Express, for Discovery and Preclinical
07-11-2001 Cubist Pharmaceuticals Chairman and CEO Scott Rocklage Appointed to MDS Proteomics' Board of Directors
07-05-2001 Allergy Testing Simplified for Patients
06-29-2001 MDS Proteomics and Abgenix Announce Exclusive Agreement to Develop Proteomic-Based Antibody Therapies
06-24-2001 MDS Nordion Invests $20 Million to Build New Commercial Cyclotron
06-22-2001 MDS Inc. Adds Pharma Executive to Board
06-19-2001 MDS Inc. Normal Course Issuer Bid
06-14-2001 MDS Reports Second Quarter Results
06-14-2001 MDS Capital Corp and Acqua Wellington Announce Formation of Vengate Capital Partners
06-12-2001 MDS Creates a Specialty Diagnostic Service for all Canadians
06-11-2001 MDS Nordion Receives FDA Clearance for its New Inverse Planning Software for IMRT
05-29-2001 PerkinElmer and MDS Sciex to Develop Next Generation TOF Mass Spectrometry Solutions for Proteomics
05-22-2001 Agilent Technologies and MDS Proteomics Work Together to Speed Protein Analysis and Drug Development
03-27-2001 MDS Inc. Announcement
03-27-2001 MDS Proteomics and Partners HealthCare Form Clinical Alliance to Speed the Discovery of New Medicines
03-20-2001 MDS Proteomics Expands Denmark and Toronto Facilities to Meet High Demand for Proteomics Research; Boston and Charlottesville Facilities to Follow
03-08-2001 MDS Reports Continued Growth in First Quarter
02-14-2001 MDS Introduces New Cervical Cancer Test
01-30-2001 Global Technology Leader - MDS Sciex - Breaks Unprecedented Ground In India
01-25-2001 Micralyne and MDS Sciex Announce Microfluidics R and D Agreement
01-25-2001 MDS Creates Canadian e-Health Platform for Physicians